Corticosteroids in the treatment of SARS-CoV-2 related lung disease
Aim. To explore the effectiveness of corticosteroids in patients with lung damage caused by SARS-CoV-2.Materials and methods. The retrospective study included patients with confirmed SARS-CoV-2 infection and lung damage diagnosed by computed tomography (CT), who was receiving low molecular weight he...
Main Authors: | V. T. Ivaschkin, O. Yu. Zolnikova, A. A. Svistunov, N. L. Dzhakhaya, N. D. Potskhverashvili, N. I. Kokina, E. R. Buklis, T. V. Roshchina, I. I. Komkova, M. Yu. Nadinskaia |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
2020-12-01
|
Series: | Сеченовский вестник |
Subjects: | |
Online Access: | https://www.sechenovmedj.com/jour/article/view/238 |
Similar Items
-
Clinical Traits of SARS-CoV-2 Infection
by: O. Yu. Zolnikova, et al.
Published: (2020-12-01) -
Clinical Efficacy of Corticosteroids in the Early Stages of Deterioration in COVID-19 Pneumonia
by: Liu Z, et al.
Published: (2021-07-01) -
Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia
by: Yvon Ruch, et al.
Published: (2020-07-01) -
The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
by: Heloísa Antoniella Braz-de-Melo, et al.
Published: (2021-04-01) -
Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
by: Liu T, et al.
Published: (2021-10-01)